Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Congratulations! Have you tried Jenny Craig?
Already doubled once and will again!!! eom
Is this the third or fourth business plan?
Whatever the count may be, they are still ZERO for income and dumping more shares all the time. That non-filing cover up is so obvious anymore.
bashola ..tssk tssk!
LOL!! You and Obi make a great comedy team. This thing isn't going anywhere. The ol' evangelist is just trying to ride the Avian flu hysteria for another pump. Isn't that right Keith?
Well I'm trying to, not much to fill below .01! Agree the positive results should catapult this to much higher levels!!! eom
ballyhooo... Are you still accumulating here? If test results come back successful I am sure that BTMD will run....:)
GL bally!
obi
BioTech Medics, Inc. Answers Questions Over Testing of Patented SHBAN(TM) Solution as Avian Bird Flu Virus Anti-Viral Disinfectant
By Market Wire
Last Update: 6/27/2006 12:22:39 PM Data provided by
DALLAS, TX, Jun 27, 2006 (MARKET WIRE via COMTEX) -- BioTech Medics, Inc. (PINKSHEETS: BTMD) announced June 23, 2006, that it has contracted with Retroscreen Virology, at the University of London, Queen Mary's School of Medicine, London to conduct a study to determine the efficacy of viricidal SHBAN against Avian HSN1 Influenza NIBRG-14 Virus (also known as the Avian Bird Flu).
"We are confident that the SHBAN solution has anti-viral properties that will kill the Avian Influenza virus upon contact without harming humans, animals and the environment," said Delton Carroll, President & CEO of FHJ Scientific and Advisor to BioTech Medics. "SHBAN has previously been tested to be a safe germicidal cleaning solution."
Questions have been raised by investors regarding the EPA's approved 90 plus disinfectant products registered and intended for use against avian influenza A viruses.
How is SHBAN different from the competition?
BioTech's Answer: The EPA approved product's list is solely for use on "hard, non-porous surfaces." Pure ammonia, bleach, gasoline even the Atomic Bomb will kill Avian Flu. Look how fire was used in 1900 in China Town in Honolulu to kill the Plague. These are not safe, non-hazardous practical ways to treat humans and animals.
The purpose of testing the SHBAN Solution in London is to prove the clear superiority of SHBAN over other disinfectants. BioTech Medics intends to prove SHBAN is 1) long lasting, it does not evaporate within one minute after application; 2) it is non-toxic (when used as directed) on humans and animals; 3) it is non-staining, non-bleaching, and has no harmful or toxic odors. Most EPA approved products cannot make these claims.
Question: How about distribution?
Upon successful completion of testing, BioTech plans on offering the SHBAN solution licensed in various forms to one or more major companies such as Pfizer, Dow, Johnson & Johnson and/or sell it directly. Products will include: SHBAN LIQUID HAND SOAP & HAND SANITIZER additive (used to apply to hands daily for long-lasting protection). This is important to hospitals/medical staff, migrant workers picking produce, food and restaurant personnel, airlines staff/passengers, poultry farmers, plants and plant workers. SHBAN Fogger Mist Solution is designed to cover large areas such as cities and wild bird sanctuaries. It will be applied just like mosquito fogger repellants. SHBAN Mister Solution will be sold to sanitize poultry, poultry buildings and wildlife areas. The SHBAN spray will be sprayed directly onto poultry or wild birds to cover them with an invisible coating of SHBAN. Prior tests on bacteria have shown the SHBAN solution to be effective up to 14 days. SHBAN EYE SOLUTION & SHBAN ANTI-BACTERIAL/ANTI-VIRUS SPRAY: FDA human clinical trials will be required.
BioTech is also considering selling a SHBAN Cat Litter additive (cats eat birds). SHBAN is protected under US Letters of Patent #4,868,213, #5,514.808, #5,574,050, #5,679,711 5,679 and #5,585,391 and several EU and other foreign patents. SHBAN is a trademark of BioTech Medics, Inc.
BioTech Medics welcomes and will provide SHBAN samples to government or world health officials should they desire to independently test the SHBAN solution.
The SHBAN(TM) solution, in previous in vitro and in vivo testing has been evaluated for its antimicrobial properties against S. Aureus, S. Epidermidis, EC. Faecalis, E. Coli and Ps. Aeruginosa. Tests revealed that SHBAN was extremely effective against all species of bacteria that were tested. Bacterial counts of the test models were reduced to < 100 bacteria per gram of tissue in the treated groups.
Keith Houser, CEO will be interviewed on www.wallst.net Tuesday, June 27, 2006. This is a news event; no compensation has been paid or received.
Failure to file : 567 days
Congratulations, Keith Houser! You are consistent in your failure and incompetence! A full 567 days of failure to be exact. It should be obvious to all that they will never file -- and we will not find out the share structure until they are revoked by the SEC.
So, if they have no intention to allow the public and their investors to ever see the financials, why are they public anyway? Free money! Its pretty easy to issue a few PRs in between issuing more shares to yourself. Sure beats working!
From a PR issued December 7, 2004
--------------------------------------------
It has been 543 days from this date
or 1 year, 6 months, 20 days
"Keith Houser announced that one of the first board actions was to interview certified public accounting firms. One key criteria for BioTech Medics to have proper standing as a reputable public company is to be an audited reporting company."
Sounds to me like a promise to file. We know the accounting work is done from another PR, so what could be the ugly truth they are hiding? They have a history of secret dilution, so its wise to expect more. Lots more.
Sounds like a total lack of focus to me
What, are we on business plan #3 or #4 by now? Isn't this new unrelated "bird flu un-tested miracle cure" venture a sign that the management suffers from a serious lack of focus? Incompetence? Stupidity?
I think these losers need to FILE before they start yet another money losing side venture.
BioTech Medics, Inc. Has Contracted for Tests of Patented SHBAN Solution as Proven Avian Bird Flu Virus Anti-Viral Disinfectant
By Market Wire
Last Update: 6/23/2006 12:31:25 PM Data provided by
DALLAS, TX, Jun 23, 2006 (MARKET WIRE via COMTEX) -- BioTech Medics, Inc. (PINKSHEETS: BTMD) announced today that it has contracted with Retroscreen Virology, at the University of London, Queen Mary's School of Medicine, London to conduct a study to determine the efficacy of viricidal SHBAN against Avian HSN1 Influenza NIBRG-14 Virus (also known as the Avian Bird Flu).
"We are confident that the SHBAN solution has anti-viral properties that will kill the Avian Influenza virus upon contact without harming humans, animals and the environment," said Delton Carroll, President & CEO of FHJ Scientific and Advisor to BioTech Medics. "SHBAN has previously been tested by Baylor Medical Center in Houston, Louisiana State University, UT Houston, Allergan, Pathology Associates, MBA Labs and Texas A&M College of Veterinary Medicine. SHBAN has tested to be a safe germicidal cleaning solution."
The clear superiority of SHBAN over other disinfectants is that SHBAN is long lasting, it does not evaporate within one minute after application; it is non-toxic (when used as directed), it is non-staining, non-bleaching, and has no harmful or toxic odors.
Upon successful completion of testing, the SHBAN solution will be sold in various forms such as SHBAN Hand Sanitizer or licensed out to be a hand sanitizer additive ingredient and SHBAN Fogger Mist to cover large areas. SHBAN Mister Solution will also be sold to sanitize infected poultry buildings and wildlife areas which are potential areas for contamination with Avian Influenza. BioTech is also considering selling a SHBAN Cat Litter additive. SHBAN should be considered for preventive measures to spray non-infected areas. SHBAN is protected under US Letters of Patent #4,868,213, #5,514.808, #5,574,050, #5,679,711 5,679 and #5,585,391 and several EU and other foreign patents.
BioTech Medics will provide SHBAN samples to government or world health officials should they desire to independently test the SHBAN solution.
The SHBAN(TM) solution, in previous in vitro and in vivo testing, has been evaluated for its antimicrobial properties against S. Aureus, S. Epidermidis, EC. Faecalis, E. Coli and Ps. Aeruginosa. Tests revealed that SHBAN was extremely effective against all species of bacteria that were tested. Bacterial counts of the test models were reduced to < 100 bacteria per gram of tissue in the treated groups, while bacteria counts remained at 6 x 10/5 CFU/GM over 14 days in the untreated control groups.
Retroscreen Virology!!! http://www.retroscreen.com/
Looks very strong here... :)))
Yes indeed! News was good and the volume is impressive on a Friday!!! eom
BTMD is doing very nice with great volume today on the news. Looks like the golden cross may be getting closer as well. www.otctrendfinders.com
Call in with your questions!!! eom
News out for Monday!!
DALLAS, TX -- (MARKET WIRE) -- 06/16/06 -- BioTech Medics, Inc. (PINKSHEETS: BTMD) announces that Market News First (http://www.mn1.com/) will be interviewing Keith Houser, CEO, "live" on their "MN1Radio Morning Program" Monday, June 19, at 9:30AM-CDST.
Market News First's one-on-one interviews with the Presidents and CEOs of microcap companies, broadcast on Market News First's website, delivers answers to the questions that microcap investors would ask, such as the companies' present conditions and future plans. This interview is not a paid endorsement of the company, but a live, non-compensated news event.
Interested investors who would like to hear the live news event can log onto MN1Radio's web site listed above and click on Monday's daily morning interview listing.
Mr. Houser was briefly featured on MN1Radio on June 9. Since that interview, according to Mark Gage, MN1Radio has received a large number of inquiries over BioTech Medics and the staff thought it best to bring Mr. Houser back to MN1Radio and do a more in-depth Q&A session.
One Hot Topic to be addressed is "How are the patented topical SHBAN disinfectant solution tests coming along concerning the effectiveness of SHBAN on the Avian Bird Flu Virus?" BioTech announced over a week ago: "We are confident that the SHBAN solution has anti-viral properties that will kill the Avian Influenza virus upon contact without harming humans, animals and the environment," said Delton Carroll, President & CEO of FHJ Scientific and Advisor.
BioTech Medics is a multi-faceted 21st Century Alternative Medicine company offering drug-free and surgery-free medical therapeutic laser treatments at 5 Pain Management & Wellness Centers in the USA (more opening soon).
Safe Harbor for Forward-Looking Statements.
This press contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 (the "Act"). In Particular, when used in the preceding discussion, the words "plan," "confident that," "believe," "scheduled," "expect," or "intend to," and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements.
BioTech Medics Negotiating Fort Worth Affiliate Pain Management Clinic
06/14/2006 10:38
DALLAS, TX -- (MARKET WIRE) -- 06/14/06 -- BioTech Medics, Inc., (PINKSHEETS: BTMD) announced today that they entered into negotiations with an existing Fort Worth Chiropractic Practice to become a BioTech Medics Pain Management & Wellness Center. One of the doctors in the group upon personally receiving a sample therapeutic laser treatment was amazed that in 15 minutes his lingering shoulder pain had subsided so quickly without drugs or steroid shots. The Fort Worth center could be open within the next month.
BioTech opened on a Saturday-only basis its Muenster, Texas center on June 10th. "The doctor and I had a good time going to Muenster and meeting new patients there," said Keith Houser, CEO. "The Texas town's German historical background is very unique."
"This will provide a convenient location for patients in North Texas and the Southern Oklahoma area to be treated. With the high cost of gasoline, this will save patients money from having to travel about 200 miles round trip to Dallas for treatment," said Mr. Houser.
There are currently 6 affiliated centers utilizing the NeuroLase Medical Laser located in Albuquerque, NM, Boca Raton, FL, Overland Park, KS, Austin, Dallas and Muenster, Texas.
BioTech Medics is a distributor for the FDA cleared NeuroLase Therapeutic Medical Laser. The NeuroLase is one of the most powerful Class 3B therapeutic lasers in the USA which is for the temporary reduction or elimination of muscular, skeletal and arthritic pain without drugs or surgery for the entire body.
Medical practitioners seeking to provide quick and safe, drug-free pain management for their patients are encouraged to contact BioTech Medics.
On the web at: www.biotechmedics.com
BioTech Medics, Inc., a 1997 Nevada public corporation
(Pinksheets symbol: BTMD)
Total Authorized Common Shares : 500,000,000
Freely Trading Outstanding Common Shares (O/S): 107,582,531
(as of 5/26/2006) Source DTC
STOCK TRANSFER AGENT INFORMATION:
If you are an existing shareholder, attorney for a shareholder
registered brokerage firm or registered investment advisor;
Contact information for the company transfer agent:
First Global Stock Transfer
7361 Prairie Falcon Road, Suite # 110
Las Vegas, NV 89128
Phone 702-656-4919 between 9AM-3PM-PST
Failure to file : 543 days
Congratulations, Keith Houser! You are consistent in your failure and incompetence! A full 543 days of failure to be exact. It should be obvious to all that they will never file -- and we will not find out the share structure until they are revoked by the SEC.
So, if they have no intention to allow the public and their investors to ever see the financials, why are they public anyway? Free money! Its pretty easy to issue a few PRs in between issuing more shares to yourself. Sure beats working!
From a PR issued December 7, 2004
--------------------------------------------
It has been 543 days from this date
or 1 year, 5 months, 27 days
"Keith Houser announced that one of the first board actions was to interview certified public accounting firms. One key criteria for BioTech Medics to have proper standing as a reputable public company is to be an audited reporting company."
Sounds to me like a promise to file. We know the accounting work is done from another PR, so what could be the ugly truth they are hiding? They have a history of secret dilution, so its wise to expect more. Lots more.
NEWS - BioTech Medics, Inc. Seeking Testing of Patented SHBAN Solution as Anti-Viral Disinfectant for Use Against Bird Flu Virus
http://biz.yahoo.com/prnews/060512/nyf040.html?.v=45
DALLAS, May 12 /PRNewswire/ -- BioTech Medics, Inc., has contacted the Center for Disease Control in Atlanta to seek testing of SHBAN Solution as an anti-viral disinfectant in killing the Avian Influenza, Influenza A (HA & NA) Bird Flu viruses in topical and field use.
The SHBAN(TM) solution, in previous in vitro and in vivo testing has been evaluated for its antimicrobial properties against S. Aureus, S. Epidermidis, EC. Faecalis, E. Coli and Ps. Aeruginosa. Tests revealed that SHBAN was extremely effective against all species of bacteria that were tested. Bacterial counts of the test models were reduced to <100 bacteria per gram of tissue in the treated groups, while bacteria counts remained at 6 x 10/5 CFU/GM over 14 days in the untreated control groups.
"We are confident that the SHBAN solution has anti-viral properties that will kill the Avian Influenza virus upon contact without harming humans, animals and the environment," said Delton Carroll, President & CEO of FHJ Scientific and Advisor to BioTech Medics. "SHBAN has previously been tested by Baylor Medical Center in Houston, Louisiana State University, UT Houston, Allergan, Pathology Associates, MBA Labs and Texas A&M College of Veterinary Medicine. When used in diluted dosages SHBAN has tested to be safe around humans and animals and very effective as a germicidal cleaning solution. Upon successful completion of testing, the SHBAN solution will be sold to sanitize infected areas which are currently contaminated with Avian Influenza, such as wildlife bird habitats, poultry farms, duck and geese nesting areas. SHBAN may be considered for preventive measures to spray non-infected areas."
SHBAN is protected under US Letters of Patent #4,868,213, #5,514.808, #5,574,050, #5,679,711 5,679 and #5,585,391.
BioTech Medics will provide SHBAN samples to world health officials to test against Avian Influenza. The public may contact BioTech to acquire SHBAN by calling 972-274-5533.
Contact: Keith Houser, CEO
On the Web: http://www.biotechmedics.com
Safe Harbor: Forward-Looking Statements.
This release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 (the "Act"). In Particular, the words "plan," "confident that," "believe" and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks, uncertainties and results could differ materially from those expressed in the forward-looking statements.
More dilution?
Rumor has it that another 30 million shares were dumped. This is as still yet unconfirmed. Looks bad if true.
Failure to file: 465 days
From a PR issued December 7, 2004
It has been 465 days from this date
1 year, 3 months, 10 days
Keith Houser announced that one of the first board actions was to interview certified public accounting firms. “One key criteria for BioTech Medics to have proper standing as a reputable public company is to be an audited reporting company."
Sounds to me like a promise to file. We know the accounting work is done from another PR, so what could be the ugly truth they are hiding?
Good resource for old PR's
http://www.biospace.com/news_company.aspx?companyID=879920
Thanks Obi!
Hey Aduke.
If I run across any others, I will let you know. I just know that MSNC has a good chance to move with vol. If I run into any others, I will keep you posted...
obi
BTW, if there is someone worth researching, it would probably be William Seminario. I know I'd sure love to know more about this person.
BTMD paid $995 apparently through a veiled method in order to get that information out there. It's obvious there are now paid posters on the other stock site attempting to blast this news across the internet.
In my opinion, it's a guy out of the Satellite Beach, Florida area doing this, not slurpit as everyone assumes. This poster in the past used aliases ending in "girl" and "woman" to help send out his message. He also used many of the fake surfit aliases(if there can be such a thing).
Bottom line.....I'll be amazed if another pump and dump is possible to these shareholders, although, I'd also be amazed if it weren't. JMO, of course.
A certain sign of desperation. Join that with the sudden appearance of All*n, the verbal vomit posted by surfit and the lawsuit, and it indicates to me that Houser and the 12 knights are in trouble. BIG trouble.
I would not be surprised to learn that surfit and the bloated volleyball boy were behind BTMD's use of buyins.net. It's the pink penny pig version of "Custer's Last Stand." The ending will be the same.
Wow, these guys are dumb.
Check out the buyins website. Its the Holy Grail of stock scammer paranoia enhancement. Here's what I think their new tag line should be:
"Is your crappy company losing money? Blame the shorts! We'll show you how for a small fee."
http://www.buyins.net/
Solutions to Naked Short Selling
BUYINS.NET has one goal: to even the playing field between institutional shorts and shareholders who have purchased bonafide ownership positions in US companies.
For decades Wall Street has been an enabler to nefarious trading activity in US stocks. By allowing short sellers to attack US stocks and sell stock that they do not own, a counterfeit stock printing press has gone unchecked. Even though the NASD and SEC have regulations that govern the legal short selling of stocks, there are countless loopholes that onshore and offshore institutions use to relentlessly attack US companies. This illegal activity is called "naked short selling".
Information is power. And finding out the "who, what, where" of this illegal naked short selling is what BUYINS.NET is doing. For the first time in history, the investing public is able to pull back the drapes on short selling activity and see which stocks are being attacked. But that is just the beginning. Once we find out who is being illegally shorted, we go the next step to find out at what prices these stocks have been shorted, what amounts have been shorted and with enough investigation, who is illegally shorting the stocks.
The devil is in the details. For the first time we will show you every short selling trade done in stocks on our lists. We will calculate the number of shares and the average price at which the stock was shorted. In essence, we will provide bonafide shareholders with the information as to what price the illegal naked short sellers will start losing money. Why is this important? Because if the government is not going to close the loopholes in new guidelines such as "Regulation SHO", then we can try to do it for them.
The best defense is a good offense. Every week we will profile a company that has been on the "naked short list" for at least 13 consecutive trading days. We will then show you the amount of short selling in the stock, the prices at which the stock was shorted and the average price where all the short sales will be out-of-the-money. Visit the TRADE SIGNALS portion of our site to get an in-depth report on the profiled company. BUYINS.NET will then alert institutions, high net worth individuals and sophisticated traders as to the "Special Situation".
There is no punishment more effective than losing money. BUYINS.NET will alert Wall Street and you as to what it takes to attack each of these illegal short sellers. There will be daily updates as to the status of the "failure to deliver" in each company’s stock and monthly updates as to the detailed short trading activity of each company’s stock. Browse our web site, peek behind the drapes and help shareholders take back their companies!
my opinion is the PR published proprietary data of BTMD, acknowledged that BTMD did not authorize the statements, and that BTMD paid for the data...
In otherwords, Keith should sue them for disclosing proprietary data since he was so hot on duderama for repeating press releases (public info).
Oh, that and it's total BS pump effort BY Keith using an arm's length pump so he can sell shares for 2 cents again.
That is my 2 cents worth.
Uh-oh, the infamous "shorty" defense
My opinion? Combined with the news of a lawsuit, secret dilution, and threatened legal action against message board posters, this is the beginning of the end. Yup, we now have all the signs of the 'death spriral' in place.
What blows my mind about the "shorty did it!" tired diversionary tactic is that, statistically, most trades on OTCBB stocks are short. That's because the general consesus is that most of them suck with large lips, especially when they stop filing to hide dilution. Pumper-scammers hope you don't notice that short sales are just as legal as long ones. Here's my headline:
"BTMD sucks so bad most people think it will continue to drop, so be smart and short it."
Not really news, is it?
Any opinion on this?
TIA
BioTech Medics (BTMD) Hires BUYINS.NET Over Stock Short Data
Jan 17, 2006 1:00:00 PM
DALLAS, Jan. 17 /PRNewswire-FirstCall/ -- BioTech Medics, Inc. (OTC Pink Sheets: BTMD), announces the hiring of BUYINS.NET. (http://www.buyins.net ). BUYINS.NET is initiating coverage of (OTC Pink Sheets: BTMD) after releasing the latest short sale data through January 12th, 2006. From January 2005 to early January 2006, approximately 108.4 million total aggregate shares of BTMD have traded for a total dollar value of nearly $2.14 million. The total aggregate number of shares shorted since January 2005 is approximately 8,351,702 shares. The BTMD SqueezeTrigger price of $0.02 is the volume weighted average short price that all shorts are short shares of BTMD. A short squeeze is expected to begin at $0.02, the volume weighted average price where all 8.35 million shares of BTMD have been shorted. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://buyins.net/squeezetrigger.pdf .
Total Short Avg. Short Dollar
Month Volume Volume Price Value
January '05 4,814,122 370,687 $0.078 $28,913
February 9,649,443 743,007 $0.0575 $42,722
March 7,523,672 579,322 $0.0475 $27,517
April 3,100,115 238,708 $0.032 $7,638
May 2,938,651 226,276 $0.0255 $5,770
June 3,330,360 256,437 $0.0163 $4,179
July 1,983,493 152,728 $0.0115 $1,756
August 5,976,702 460,206 $0.0158 $7,271
September 7,655,954 589,508 $0.007 $4,126
October 2,494,677 192,090 $0.007 $1,344
November 23,584,936 1,816,040 $0.0064 $11,622
December 30,269,816 2,330,775 $0.0083 $19,345
January '06 5,141,725 395,912 $0.0071 $2,810
Total: 108,463,666 8,351,702 $0.02 $165,020
* short volume is approximated using a proprietary algorithm
** average short price is calculated using a volume weighted average
short price.
*** short volume is the total short trade volume and does not account for
covers.
BioTech Medics has acquired over $2.5 million in assets last year (with cash and treasury stock) and has a steady revenue income in the management agreement with Charles R. Crane MD & Associates in forming our first Pain Management & Wellness Center in Dallas, Texas. Additionally BTMD acquired 5 US Letters of Patent from FHJ and have started marketing the proprietary SHBAN Cleaning & Disinfecting Solution which has anti-mold, anti-fungus properties without the use of bleaches. BTMD entered into a distributorship agreement with Laser Neurotherapy Development Labs and have sold the NeuroLase Medical Laser device to clinics in the USA. We negotiated turnkey financing for the laser acquisitions through First Financial Leasing & Financing.
BTMD plans on closing on more new Pain Management & Wellness Centers in 2006, as well as acquiring a permanent office building in Dallas, Texas. "We pledge to strive to add more assets and increased revenue for the company to bring more value to the stock and its more than 5,800 shareholders in 22 countries," said Keith Houser, CEO. "This in turn should provide BTMD the opportunity to become a reporting company."
WWW.BUYINS.NET is a service to help bonafide shareholders of publicly traded US companies fight short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. BUYINS.NET has a proprietary database that uses list feeds to generate detailed information to combat the short selling problem. Actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable, but is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The company that is discussed in this opinion has not approved the statements made in this opinion. BioTech Medics purchased $995.00 worth of data used to generate this report. This PR and opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. BUYINS.NET will not advise when to sell and does not offer any opinion as to when others should sell.
SOURCE BioTech Medics, Inc.
----------------------------------------------
BioTech Medics
Inc.
+1-972-274-5533
but some arguments start on RB and end up here (same participants)
Guys, anything going on at Raging Bull is not a topic here. On iHub, please stick to talking about this stock.
panther: another theory
Since Treffrey is 'working' for BTMD, it seems obvious and likely to me that he is using his years of experince and notes on RB posters to inform Keith as to the various poster's identities. As you stated, some of that information is incomplete or incorrect, but they are desperate to itimidate those they see as the oppostion to their ability to profit.
By 'working', I suggest that Treffrey has some motivation, whether or not he is paid in shares. (Cash is unlikely as they are deep in the red by now.) By his own admissions, we also know he owns a large amount of shares and has been highly defensive with regards to BTMD skeptics in the past, although not as much lately. I further theorize that Treffrey is assisting, since he has worked for shares in the past, and seems doomed to repeat his mistaken involvement with non-filing scammers. If LoCastro can fool you, anyone can.
I therfore don't think that RB is involved, nor is there any hacking going on. Those activities seem to sophisticated for these non-filing scam-ateurs.
Are you saying you think Treffry is not as he claims?? Surely you jest?
Yeah, I know. But, I've been reading the thread between you and Tref on RB and he is spelling it Hauser ... which is, I think, just a little attempt at deception on his part. Remember, he is the one who mysteriously acquired a boat load of Corbel/BTMD shares months before the RS. I don't think that was due to "widom" on his part. I think he is well connected with the boyz and Houser.
I'll PM you when I catch a "Happy Hour."
For your info, it's Houser, not Hauser.
Neither do I. They are not the only ones who have had, and still do have, multiple aliases. based on that and similar situations, one could easily assume that RB is in, or at least very chummy, with the scammers themselves. I to have TOSed SBG and All*n for multiple aliases and given RB tons of proof ... all to no avail.
Based on a couple of emails to me from Hauser, I am almost certain he has a good inside connection and gets some sensitive information from them or someone on their payroll. If I could absolutely prove it, I would go after both of them.
No problem. I know you are trying to piece the puzzle together an that was one piece you had out of place. I'll be interested to see what you come up with. heaven knows I don't have the time to do it.
Not entirely true. SBG and Allan have both had numerous aliases. What amazes me is Frank Love is spamming his company on RB under many different obvious aliases, and even though I continually TOS them, they remain?? I don't get it?
Yeah, that was a shoot from the hip comment. Since then I've done a bit of research. Sorry for any misconceptions.
I'd be cautious too, fung. I don't believe that Whitey/Hauser wants you in there for your health. there has to be other laser treatment centers in your area, anyway.
Whitey sure wants me in there for my free treatment. The pisser is, I could really use it!
Uh, fung! Trust me, scanner is not Adam. (If that is what you meant to say)
I'm assuming scanner if Adam?
What in the heck?? I'm totally confused now....
Source: Adam Barnett
Adam Barnett, Chairman of OMDA Oil & Gas, Inc. Addresses Press Release Issued by BioTech Medics, Inc. Dated November 21, 2005
HOUSTON, Nov. 23, 2005 (PRIMEZONE) -- Adam Barnett, Chairman of OMDA Oil and Gas, Inc., responded today to the BioTech Medics, Inc. (Pink Sheets:BTMD) press release issued on November 21, 2005.
In the press release issued by BioTech Medics, Inc., it was stated that OMDA Oil & Gas, Inc. Chairman Adam Barnett was the CEO of OMDA Oil and Gas, Inc. and represented Mr. William Seminario, President of Hamilton Holdings P.A. while entering into a contract and executing a $1 million Promissory Note. Mr. Adam Barnett has never previously and does not currently have any affiliation with Hamilton Holdings P.A. Mr. Adam Barnett has never represented Mr. William Seminario. Mr. Barnett's position within the OMDA Oil & Gas, Inc. organization is solely as Chairman.
In response to the press release issued by BioTech Medics, Inc., Mr. Barnett is discussing with counsel any future action that may be necessary.
CONTACT:
For Adam Barnett
Tipton Jones LLP
Andrew L. Jones, Esq.
214-979-0100 ext. 249
214-303-1812 fax
i love it when con-men quibble amongst themselves. very entertaining stuff.
Actually, in looking back and trying to piece things together, I'm assuming scanner if Adam? Between one scam to the next, I can't keep the players straight.
Whitey sure wants me in there for my free treatment. The pisser is, I could really use it!
Followers
|
11
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
339
|
Created
|
10/24/03
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |